Page last updated: 2024-08-23

fluorides and Prostatic Neoplasms, Castration-Resistant

fluorides has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Duan, F; Jeraj, R; Mankoff, DA; Muzi, JP; Muzi, M; O'Sullivan, F; Perk, TG; Yu, EY	1
Etchebehere, E; Kairemo, K; Macapinlac, HA; Milton, DR; Rohren, EM	1

Trials

1 trial(s) available for fluorides and Prostatic Neoplasms, Castration-Resistant

Article	Year
Whole-Body [ Tomography (Ann Arbor, Mich.), 2021, 04-25, Volume: 7, Issue:2 Topics: Dasatinib; Fluorides; Fluorine Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Sodium Fluoride; Tomography, X-Ray Computed	2021

Other Studies

1 other study(ies) available for fluorides and Prostatic Neoplasms, Castration-Resistant

Article	Year
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience. Current radiopharmaceuticals, 2018, Volume: 11, Issue:2 Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium	2018

Article

Year

Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience.

Current radiopharmaceuticals, 2018, Volume: 11, Issue:2

Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium

2018